ScholarIQanswers from OpenAlex & ORCID
David D’Cruz
ResearcherPublications, citations & collaboration network
David D’Cruz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David D’Cruz have?
ScholarIQindexed works
David D’Cruz has 496 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David D’Cruz have?
ScholarIQcitation count
David D’Cruz has 18,616 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David D’Cruz?
ScholarIQh-index
David D’Cruz has an h-index of 65 in OpenAlex.
What is the i10-index of David D’Cruz?
ScholarIQi10-index
David D’Cruz has an i10-index of 206 in OpenAlex.
What is the ORCID of David D’Cruz?
ScholarIQorcid
The ORCID for David D’Cruz is on the source record.
What is the OpenAlex record for David D’Cruz?
ScholarIQopenalex
The OpenAlex for David D’Cruz is on the source record.
What are the most-cited papers on David D’Cruz?
ScholarIQmost cited works
Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors
Jérôme Cros, Nicolas Cagnard, Kevin Woollard, Natacha Patey, Shen‐Ying Zhang, Brigitte Sénéchal, Anne Puel, Subhra K. Biswas, Despina Moshous, Capucine Pïcard, Jean‐Philippe Jais, David D’Cruz, Jean‐Laurent Casanova, Céline Trouillet, Frédéric Geissmann
Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide
Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz, Gian Domenico Sebastiani, Enrique de Ramón Garrido, Maria Giovanna Danieli, Daniel Abramovicz, Daniël Blockmans, Alessandro Mathieu, Haner Di̇reskeneli̇, Mauro Galeazzi, Ahmet Gül, Yair Levy, P Petera, Rajko Popović, Radmila Petrović, Renato Alberto Sinico, Roberto Cattaneo, Josep Font, Geneviève Depresseux, Jean‐Pierre Cosyns, Ricard Cervera
Systemic lupus erythematosus
David D’Cruz, Munther A. Khamashta, Graham R.V. Hughes
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
David Isenberg, Anisur Rahman, Elizabeth Allen, Vernon T. Farewell, Mohamed Akil, Ian N Bruce, David D’Cruz, Bridget Griffiths, Munther A. Khamashta, Peter J. Maddison, Neil McHugh, M. L. Snaith, Lee Suan Teh, Chee‐Seng Yee, Asad Zoma, Caroline Gordon
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
Susan Manzi, Jorge Sánchez‐Guerrero, Joan T. Merrill, Richard Furie, Dafna D. Gladman, Sandra Navarra, Ellen M. Ginzler, David D’Cruz, Andrea Doria, Simon Cooper, Z. John Zhong, Douglas R. Hough, William W. Freimuth, Michelle Petri